Gryphon Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.56M | Buy |
3,104
+467
| +18% | +$224K | 0.14% | 108 |
|
|
2026
Q1 | $1.3M | Buy |
2,637
+261
| +11% | +$142K | 0.13% | 105 |
|
|
2025
Q4 | $1.38M | Buy |
2,376
+335
| +16% | +$189K | 0.15% | 94 |
|
|
2025
Q3 | $990K | Buy |
2,041
+99
| +5% | +$46.1K | 0.11% | 115 |
|
|
2025
Q2 | $788K | Sell |
1,942
-30
| -2% | -$12.5K | 0.1% | 132 |
|
|
2025
Q1 | $981K | Buy |
1,972
+271
| +16% | +$147K | 0.14% | 100 |
|
|
2024
Q4 | $885K | Sell |
1,701
-35
| -2% | -$19.2K | 0.13% | 97 |
|
|
2024
Q3 | $1.07M | Buy |
1,736
+162
| +10% | +$95.9K | 0.15% | 89 |
|
|
2024
Q2 | $871K | Buy |
1,574
+163
| +12% | +$93.4K | 0.13% | 97 |
|
|
2024
Q1 | $820K | Sell |
1,411
-73
| -5% | -$41K | 0.14% | 101 |
|
|
2023
Q4 | $794K | Buy |
1,484
+116
| +8% | +$56.1K | 0.14% | 105 |
|
|
2023
Q3 | $693K | Sell |
1,368
-5
| -0.4% | -$2.66K | 0.16% | 70 |
|
|
2023
Q2 | $716K | Sell |
1,373
-52
| -4% | -$28.1K | 0.16% | 72 |
|
|
2023
Q1 | $821K | Sell |
1,425
-23
| -2% | -$13K | 0.19% | 62 |
|
|
2022
Q4 | $797K | Sell |
1,448
-1
| -0.1% | -$530 | 0.19% | 67 |
|
|
2022
Q3 | $735K | Buy |
1,449
+86
| +6% | +$48.1K | 0.19% | 63 |
|
|
2022
Q2 | $740K | Buy |
1,363
+7
| +0.5% | +$3.85K | 0.18% | 61 |
|
|
2022
Q1 | $801K | Sell |
1,356
-11
| -0.8% | -$6.32K | 0.16% | 72 |
|
|
2021
Q4 | $912K | Buy |
1,367
+77
| +6% | +$48.1K | 0.17% | 70 |
|
|
2021
Q3 | $737K | Buy |
1,290
+56
| +5% | +$30.7K | 0.16% | 80 |
|
|
2021
Q2 | $616K | Buy |
1,234
+53
| +4% | +$25K | 0.14% | 73 |
|
|
2021
Q1 | $538K | Buy |
1,181
+24
| +2% | +$11.5K | 0.12% | 88 |
|
|
2020
Q4 | $538K | Buy |
1,157
+2
| +0.2% | +$938 | 0.14% | 83 |
|
|
2020
Q3 | $510K | Buy |
1,155
+123
| +12% | +$50.8K | 0.15% | 73 |
|
|
2020
Q2 | $373K | Sell |
1,032
-99
| -9% | -$33.2K | 0.12% | 92 |
|
|
2020
Q1 | $320K | Buy |
1,131
+140
| +14% | +$44.1K | 0.12% | 94 |
|
|
2019
Q4 | $322K | Buy |
+991
| New | +$300K | 0.08% | 131 |
|
|
2018
Q3 | – | Sell |
-214
| Closed | -$45K | – | 755 |
|
|
2018
Q2 | $45K | Buy |
214
+6
| +3% | +$1.27K | 0.02% | 244 |
|
|
2018
Q1 | $42K | Buy |
208
+1
| +0.5% | +$210 | 0.02% | 254 |
|
|
2017
Q4 | $40K | Buy |
+207
| New | +$39.7K | 0.02% | 287 |
|
Other funds holding TMO
Gryphon Financial Partners's TMO Position: Q2 2026 in Review
Gryphon Financial Partners increased its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2026, buying an estimated $224K and bringing the position to 3,104 shares worth $1.56M. The position accounts for 0.14% of the portfolio, ranked #108.
Gryphon Financial Partners first reported a position in TMO in Q4 2017 and has held it in 30 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Gryphon Financial Partners held 3,104 shares of Thermo Fisher Scientific worth $1.56M as of Q2 2026.
- Gryphon Financial Partners bought 467 Thermo Fisher Scientific shares in Q2 2026, an estimated $224K.
- Thermo Fisher Scientific made up 0.14% of Gryphon Financial Partners's portfolio in Q2 2026, its #108 holding.
- Gryphon Financial Partners first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 30 quarters since.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.